Radiation Therapy News and Research

RSS
Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.
Factors associated with disparities in breast cancer survival studied

Factors associated with disparities in breast cancer survival studied

New U-M study examines why overtreatment in older breast cancer patients persists

New U-M study examines why overtreatment in older breast cancer patients persists

Gene targets for triple negative breast cancers resistant to chemotherapy found

Gene targets for triple negative breast cancers resistant to chemotherapy found

New radiotherapy technology reduces treatment times with improved accuracy

New radiotherapy technology reduces treatment times with improved accuracy

Research findings can lead to new treatment for patients with fatal glandular cancer

Research findings can lead to new treatment for patients with fatal glandular cancer

Blood test may predict treatment outcomes for patients with localized NSCLC

Blood test may predict treatment outcomes for patients with localized NSCLC

Hypofractionated breast radiation therapy safe and effective in women under 50, study finds

Hypofractionated breast radiation therapy safe and effective in women under 50, study finds

Study links distress to missed appointments and hospital admission during cancer therapy

Study links distress to missed appointments and hospital admission during cancer therapy

Researchers explore new combination approach to treat high-risk soft-tissue sarcomas

Researchers explore new combination approach to treat high-risk soft-tissue sarcomas

BWH researchers identify new rare genetic cause of peritoneal mesothelioma

BWH researchers identify new rare genetic cause of peritoneal mesothelioma

Arkansas professor makes strides toward developing enhanced cancer treatment

Arkansas professor makes strides toward developing enhanced cancer treatment

Genome sequence cannot predict radiation resistance, say researchers

Genome sequence cannot predict radiation resistance, say researchers

Study identifies late effects that may interfere with work status of young adult cancer survivors

Study identifies late effects that may interfere with work status of young adult cancer survivors

Study: Chemoradiation should remain standard treatment for locally advanced cervical cancer

Study: Chemoradiation should remain standard treatment for locally advanced cervical cancer

New study finds lack of adherence to lifesaving treatment among breast cancer patients on opioids

New study finds lack of adherence to lifesaving treatment among breast cancer patients on opioids

Comprehensive program takes patient care to next level by improving lives of women with ovarian cancer

Comprehensive program takes patient care to next level by improving lives of women with ovarian cancer

ASTRO recognizes 43 researchers for their top-rated abstracts at 2017 Annual Meeting

ASTRO recognizes 43 researchers for their top-rated abstracts at 2017 Annual Meeting

Research paves way for new drugs that may prevent tumor repopulation after radiation therapy

Research paves way for new drugs that may prevent tumor repopulation after radiation therapy

Cancer treatments could affect person’s sense of taste and dietary preferences

Cancer treatments could affect person’s sense of taste and dietary preferences

Tumor irradiation may prolong survival of NSCLC patients undergoing novel chemotherapy formulation

Tumor irradiation may prolong survival of NSCLC patients undergoing novel chemotherapy formulation